SCHEMBL9890258

SCHEMBL9890258

c1ccc(-c2ccc3c(c2)c2cc(-c4ccc5sc6c(ccc7c8cc(-n9c%10ccccc%10c%10ccccc%109)ccc8sc76)c5c4)ccc2n3-c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.44
LIMK1 P53667 2/20 0.38
TSPO P30536 1/20 0.36
HDAC4 P56524 1/20 0.36
KMT2A Q03164 2/20 0.33
IL1R1 P14778 1/20 0.33
PIM3 Q86V86 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
PTGER4 P35408 1/20 0.32
PIM1 P11309 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
RAC2 P15153 1/20 0.32
RAC3 P60763 1/20 0.32
CDC42 P60953 1/20 0.32
RAC1 P63000 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9890496 0.93 L3MBTL1 (0.40) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL9890249 0.93 LIMK1 (0.40) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL19596387 0.92 L3MBTL1 (0.49) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL5028284 0.92 L3MBTL1 (0.49) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL10331652 0.92 L3MBTL1 (0.49) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL16482091 0.92 L3MBTL1 (0.41) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL20654826 0.91 L3MBTL1 (0.45) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL16482093 0.91 KDM4E (0.39) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL9890238 0.90 L3MBTL1 (0.46) L3MBTL1KDM4EATMLIMK1TSPO
SCHEMBL25672043 0.90 L3MBTL1 (0.46) L3MBTL1KDM4EATMLIMK1TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 L3MBTL1 709/4885KDM4E 990/4885ATM 3103/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 L3MBTL1 709/4885KDM4E 990/4885ATM 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.